Literature DB >> 10065809

Cost and morbidity associated with antibiotic prophylaxis in the ICU.

N Namias1, S Harvill, S Ball, M G McKenney, J P Salomone, J M Civetta.   

Abstract

BACKGROUND: Although the high cost and inappropriate use of antibiotics have been documented before, we are not aware of any data on nonsurgical site infectious morbidity associated with prolonged courses of prophylactic antibiotics (PA). STUDY
DESIGN: Data regarding antibiotic orders were collected using a custom designed microbiology database in the Surgical Intensive Care Unit of a teaching hospital from October 1, 1995 through April 30, 1997. The database was retrospectively reviewed. The cost of PA in excess of 1 day was calculated. Frequency of bacteremia and line infections were compared in patients receiving 1 day or less of PA versus more than 4 days of PA.
RESULTS: Sixty-one percent of PA orders were continued for more than 1 day. Cost of PA beyond 1 day totaled $44,893. Bacteremia and line infection were more frequent in the patients receiving more than 4 days of PA.
CONCLUSIONS: There was poor compliance with the protocol of stopping PA at 24 hours. The cost of noncompliance was $44,893. There were more bacteremias and line infections in patients with duration of PA of more than 4 days.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10065809     DOI: 10.1016/s1072-7515(98)00287-7

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  7 in total

1.  A pilot study of the noninvasive assessment of the lung microbiota as a potential tool for the early diagnosis of ventilator-associated pneumonia.

Authors:  Addison K May; Jacob S Brady; Joann Romano-Keeler; Wonder P Drake; Patrick R Norris; Judith M Jenkins; Richard J Isaacs; Erik M Boczko
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

2.  Duration of antibiotic prophylaxis in high-risk patients with penetrating abdominal trauma: a prospective randomized trial.

Authors:  E E Cornwell; W R Dougherty; T V Berne; G Velmahos; J A Murray; S Chahwan; H Belzberg; A Falabella; I R Morales; J Asensio; D Demetriades
Journal:  J Gastrointest Surg       Date:  1999 Nov-Dec       Impact factor: 3.452

3.  Determining the use of prophylactic antibiotics in breast cancer surgeries: a survey of practice.

Authors:  Sergio A Acuna; Fernando A Angarita; Jaime Escallon; Mauricio Tawil; Lilian Torregrosa
Journal:  BMC Surg       Date:  2012-08-31       Impact factor: 2.102

4.  [Antibiotic prophylaxis in clean and clean contaminated gynecological and obstetric surgeries the Yaounde General Hospital, Cameroon].

Authors:  Jean Dupont Kemfang Ngowa; Anny Ngassam; R Motzebo Mbouopda; Jean Marie Kasia
Journal:  Pan Afr Med J       Date:  2014-09-10

5.  Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity.

Authors:  Lee W Goneau; Thomas J Hannan; Roderick A MacPhee; Drew J Schwartz; Jean M Macklaim; Gregory B Gloor; Hassan Razvi; Gregor Reid; Scott J Hultgren; Jeremy P Burton
Journal:  MBio       Date:  2015-03-31       Impact factor: 7.867

6.  Antibiotic prophylaxis in organophosphorus poisoning: A study of health and economic outcomes.

Authors:  Asim Priyendu; K E Vandana; Muralidhar Varma; Nishitha Prabhu; Alsha Abdul Rahim; Anantha Naik Nagappa
Journal:  Saudi Pharm J       Date:  2016-07-30       Impact factor: 4.330

7.  A Four-Probiotic Regime to Reduce Surgical Site Infections in Multi-Trauma Patients.

Authors:  Georgios Tzikos; Despoina Tsalkatidou; George Stavrou; Giannoula Thoma; Angeliki Chorti; Maria Tsilika; Antonios Michalopoulos; Theodosios Papavramidis; Evangelos J Giamarellos-Bourboulis; Katerina Kotzampassi
Journal:  Nutrients       Date:  2022-06-24       Impact factor: 6.706

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.